PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21041072-0	2011	Expression and vitamin D3 regulation of long-chain fatty-acid-CoA ligase 3 in human prostate cancer cells.	Cholecalciferol	15-25	acyl-CoA synthetase long chain family member 3	Homo sapiens	40-74	
15556626-2	2004	In our previous studies, we found that FAS and FACL3 genes were vitamin D3-regulated and involved in the antiproliferative effect of 1alpha,25(OH)2D3 in the human prostate cancer LNCaP cells.	Cholecalciferol	72-74	acyl-CoA synthetase long chain family member 3	Homo sapiens	47-52	
15556626-0	2004	Vitamin D3 inhibits fatty acid synthase expression by stimulating the expression of long-chain fatty-acid-CoA ligase 3 in prostate cancer cells.	Cholecalciferol	0-10	acyl-CoA synthetase long chain family member 3	Homo sapiens	84-118	
15556626-6	2004	This suggests that the downregulation of FAS expression by vitamin D3 is mediated by vitamin D3 upregulation of FACL3 expression.	Cholecalciferol	59-69	acyl-CoA synthetase long chain family member 3	Homo sapiens	112-117	
15556626-6	2004	This suggests that the downregulation of FAS expression by vitamin D3 is mediated by vitamin D3 upregulation of FACL3 expression.	Cholecalciferol	85-95	acyl-CoA synthetase long chain family member 3	Homo sapiens	112-117	
15556626-7	2004	Myristic acid, one of the substrates preferential for FACL3, enhanced the repression of FAS expression by vitamin D3.	Cholecalciferol	106-116	acyl-CoA synthetase long chain family member 3	Homo sapiens	54-59	
15556626-8	2004	The action of myristic acid was abrogated by inhibition of FACL3 activity, suggesting that the enhancement in the downregulation of FAS expression by vitamin D3 is due to the formation of myristoyl-CoA.	Cholecalciferol	150-160	acyl-CoA synthetase long chain family member 3	Homo sapiens	59-64	
15556626-9	2004	The data suggest that vitamin D3-repression of FAS mRNA expression is the consequence of feedback inhibition of FAS expression by long chain fatty acyl-CoAs, which are formed by FACL3 during its upregulation by vitamin D3 in human prostate cancer LNCaP cells.	Cholecalciferol	22-32	acyl-CoA synthetase long chain family member 3	Homo sapiens	178-183	
15556626-9	2004	The data suggest that vitamin D3-repression of FAS mRNA expression is the consequence of feedback inhibition of FAS expression by long chain fatty acyl-CoAs, which are formed by FACL3 during its upregulation by vitamin D3 in human prostate cancer LNCaP cells.	Cholecalciferol	211-221	acyl-CoA synthetase long chain family member 3	Homo sapiens	178-183	
15178414-0	2004	The role of long-chain fatty-acid-CoA ligase 3 in vitamin D3 and androgen control of prostate cancer LNCaP cell growth.	Cholecalciferol	50-60	acyl-CoA synthetase long chain family member 3	Homo sapiens	12-46